Bio-Engineered Stents Market to Grow at a CAGR of 6.4% with Increasing Applications in Healthcare Sector

The demand for bio-engineered stents in 2019 was estimated at USD 2.32 Billion and is expected to grow during the forecast period at a CAGR of 6.4 percent. In the near future, growing FDA approvals for new products with better organic solutions, acquisitions, and the introduction of innovative stents within developing foreign locations would drive market growth.

Click here to get sample of the premium report: https://www.quincemarketinsights.com/request-sample-64111?utm_source=hp&utm_medium=mw&utm_campaign=hp

Cardiovascular disorders, such as coronary heart disease and ischemic heart disease, are growing in prevalence. Between 2013 and 2016, 121.5 million U.S. adults had a form of cardiovascular disease, according to the American Heart Association. In comparison, the direct and indirect costs of overall cardiovascular disorders and strokes were estimated at US$ 351.2 billion between 2014 and 2015.

The rise in hospital admissions for cardiovascular diseases and the development of bioengineered technology in the stent industry worldwide are boosting the global demand for bioengineered stents.

Major Influences Driving the Global Bio-Engineered Stents Market:

  1. The market has been segmented into dental implants and bone anchored prostheses, depending on the product. In 2019, due to the rise in the number of dental implants across healthcare products, the dental implants segment is projected to dominate the industry.
  2. During the projected period, the category of ambulatory surgery centers is projected to lead the market for bio-engineered stents in terms of the highest growth rate due to the growing focus of governments and local healthcare organizations on emergency services across nations.
  3. In 2019, the worldwide demand for bio-engineered stents is projected to account for the largest market share in terms of size and volume in North America. In addition, the region’s development is largely due to the growing prevalence of cardiovascular diseases and the boom in the release of successful stent gadgets among many players by acquisitions.

The Bio-Engineered Stents Market report explores global business prospects and evaluates competitive conditions for Bio-Engineered Stents Market size estimation and forecasts, which are determined based on a detailed research to gauge the environment of the Bio-Engineered Stents market. The demand has been analyzed to offer accurate estimations of the industry size. Crucial factors impelling the growth of the global market and driving its demand have been established to determine potential significance.

Global Bio-Engineered Stents Industry Study Offers:

  1. An overview of a thorough analysis of the global Bio-Engineered Stents Market and related technologies
  2. Identification of new market opportunities and targeted consumer marketing strategies for the global Bio-Engineered Stents Market
  3. Demand for new applications with new technologies and breakdown in the Bio-Engineered Stents Market
  4. Exhaustive scope to cover all the possible segments helping every stakeholder in the Bio-Engineered Stents market
  5. Company profiles of significant players in the Bio-Engineered Stents Market

The Bio-Engineered Stents Market study offered by the professionals’ offers an extensive market evaluation with established segments such as product type, application, and region. Every component of the different segment of the Bio-Engineered Stents market along with its sub-segments is deliberated comprehensively based on their market share, growth scenarios, and CAGR. In each market segment, quantitative information and qualitative analysis is offered with detailed information for presenting a complete Bio-Engineered Stents Market outlook.

Major corporations functioning in the global Bio-Engineered Stents market are ORBUSNEICH MEDICAL, Medtronic Plc, Abbott Laboratories, Vascular Concepts, C. R. Bard, Lombard Medical Technologies, Biotronik SE & Co. KG, Terumo Corporation, Endologix, Inc., and Translumina GmbH.

Market Segmentation:

By Product

  • Dental Implants
  • Bone Anchored Prostheses

By Material

  • Biomaterials
  • Ceramic
  • Metallic
  • Polymers

By End User 

  • Ambulatory Surgical Centers
  • Hospitals and Dental Clinic

By Region:

  • North America Bio-Engineered Stents Market
    • By Country (US, Canada, Mexico)
    • By Product
    • By Material
    • By End User
  • Europe Bio-Engineered Stents Market
    • By Country (Germany, Russia, UK, France, Spain, Europe)
    • By Product
    • By Material
    • By End User
  • Asia Pacific Bio-Engineered Stents Market
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Product
    • By Material
    • By End User
  • Middle East & Africa Bio-Engineered Stents Market
    • By Country (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa)
    • By Product
    • By Material
    • By End User
  • South America Bio-Engineered Stents Market
    • By Country (Brazil, Argentina, Colombia, Rest of South America)
    • By Product
    • By Material
    • By End User

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

 

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

 

Contact:

Quince Market Insights

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986

Email: [email protected]

Web: www.quincemarketinsights.com

 

Leave a comment

Your email address will not be published. Required fields are marked *